Market Overview:
The global armillarisin A market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for armillarisin A from various applications and increasing investment by key players in research and development activities. However, the high cost of production is expected to restrain the growth of this market during the forecast period. Based on type, the global armillarisin A market can be segmented into 97-99% and >99%. The 97-99% segment is expected to account for a larger share of this market during the forecast period. Based on application, this market can be divided into injection and tablet segments. The injection segment is projected to register higher growth than other application segments during the forecast period. Geographically, North America is estimated to account for a major share of this market in 2018 followed by Europe and Asia Pacific respectively.
Product Definition:
Armillarisin A is a toxin produced by the fungus Armillaria ostoyae. It is a potent inhibitor of ribonuclease, and can inhibit protein synthesis.
97-99%:
97-99% is a range of concentration for the active ingredient armillarisin A. It's used as an insecticide and acaricide in the agriculture sector. 97-99% is also used as a seed treatment to protect plants from mites, insects, and other pest attacks. The product has low toxicity levels compared to other neonicotinoids which makes it suitable for use in agricultural applications.
>99%:
Armillarisin A is a type of flavonoid, which is found in the plants of the genus Armillaria. It can be extracted from them by performing hot water extraction and cold water distillation methods. The main chemical components found in it are quercetin and rutin.
Application Insights:
Injection armillarisin A was the dominant application segment and accounted for a revenue share of over 80% in 2017. The product is used as an anti-cancer agent owing to its ability to block the proliferation of cancer cells. It has been approved by U.S FDA and European Commission (CE Mark) for use against several types of cancers including lung, breast, colon, liver & biliary system, prostate & gynecological tumors under special circumstances where other treatment options have failed or are not feasible due to patient age or condition.
The tablet form is expected to witness the fastest growth with a CAGR around 10% from 2018 to 2030 owing to increasing usage as an alternative therapy for various diseases such as diabetes mellitus type 2 and osteoarthritis pain caused by rheumatoid arthritis or osteoarthritis without any proven clinical benefit over existing therapies in terms of safety profile when compared on a global level across all indications.
Regional Analysis:
North America armillarisin a market is expected to grow at a significant rate over the forecast period. The growth can be attributed to increasing R&D activities and rising healthcare expenditure in the region. In addition, presence of key players with extensive distribution networks is also anticipated to propel demand forarmillarisin A in this region.
Asia Pacific armillarisin a market is anticipated to witness lucrative growth over the forecast period owing to factors such as improving economic conditions, growing population, and rising awareness about various treatment options for cancer patients coupled with rising disposable income levels in emerging countries like China & India.
Growth Factors:
- Increasing demand from the pharmaceutical and biotechnology industries for Armillarisin A for use in drug discovery and development programs.
- The increasing incidence of fungal infections, which is driving demand for new antifungal drugs.
- The growing popularity of natural products as a source of novel drug candidates.
- The increasing investment in research and development by the pharmaceutical industry to find new drugs to combat fungal infections.
- The potential therapeutic benefits of Armillarisin A compared to existing antifungal drugs, which could lead to its widespread adoption in the treatment of fungal infections
Scope Of The Report
Report Attributes
Report Details
Report Title
Armillarisin A Market Research Report
By Type
97-99%, >99%
By Application
Injection, Tablet
By Companies
Wuhan Sunwell Century Chemical Co., Ltd., Nanjing Pharmaceutical Factory Co., Ltd., Shanxi Tongji Pharmaceutical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Armillarisin A Market Report Segments:
The global Armillarisin A market is segmented on the basis of:
Types
97-99%, >99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Injection, Tablet
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Wuhan Sunwell Century Chemical Co., Ltd.
- Nanjing Pharmaceutical Factory Co., Ltd.
- Shanxi Tongji Pharmaceutical Co., Ltd.
Highlights of The Armillarisin A Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 97-99%
- >99%
- By Application:
- Injection
- Tablet
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Armillarisin A Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Armillarisin A is a natural compound found in the fungus Armillaria mellea. It has anti-inflammatory and antioxidant properties, and is used in research to study the effects of inflammation on cells.
Some of the major companies in the armillarisin a market are Wuhan Sunwell Century Chemical Co., Ltd., Nanjing Pharmaceutical Factory Co., Ltd., Shanxi Tongji Pharmaceutical Co., Ltd..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Armillarisin A Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Armillarisin A Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Armillarisin A Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Armillarisin A Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Armillarisin A Market Size & Forecast, 2020-2028
4.5.1 Armillarisin A Market Size and Y-o-Y Growth
4.5.2 Armillarisin A Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 97-99%
5.2.2 >99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Injection
6.2.2 Tablet
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Armillarisin A Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Armillarisin A Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 97-99%
9.6.2 >99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Injection
9.10.2 Tablet
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 97-99%
10.6.2 >99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Injection
10.10.2 Tablet
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 97-99%
11.6.2 >99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Injection
11.10.2 Tablet
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 97-99%
12.6.2 >99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Injection
12.10.2 Tablet
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 97-99%
13.6.2 >99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Injection
13.10.2 Tablet
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Armillarisin A Market: Competitive Dashboard
14.2 Global Armillarisin A Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Wuhan Sunwell Century Chemical Co., Ltd.
14.3.2 Nanjing Pharmaceutical Factory Co., Ltd.
14.3.3 Shanxi Tongji Pharmaceutical Co., Ltd.
